Iroko Cardio International Chooses Veeva CRM for European-wide Deployment

By Veeva Systems, PRNE
Wednesday, May 18, 2011

BARCELONA, May 19, 2011 - Iroko Cardio International (Geneva, Switzerland), a privately held
pharmaceutical company dedicated to reducing the incidence of major adverse
cardiac events (MACE), has adopted Veeva CRM to support all of its
representatives in nine European countries. Both field and office-based users
have begun to leverage the advanced functionality of the new system to manage
their customer information and interactions, citing quick deployment, ease of
use, cost efficiency, and scalability as key benefits thus far.

"I've lived through several CRM implementations before, and the 'sell' to
end users was never easy," confided Juergen Guenther, vice president of
customer operations at Iroko. "I'm pleased to say that the feedback on
Veeva's system has been very positive. Users appreciate the well-designed
interface, the features we've added to the standard version, and the quick
screen refresh times."

Veeva's Professional Services team worked closely with Iroko Cardio to
deploy the Veeva CRM system to all users in only six weeks. Time to market
was a major advantage over traditional client/server CRM systems, which
typically require a minimum of three to six months to deploy.

"As a small, but pan-European company, we weren't able to embark on a
lengthy requirements definition, configuration, and implementation exercise,"
explained Guenther. "With Veeva, we were spared that; we experienced a very
fast, user-oriented design phase for changes to the basic system, often with
immediate response on design requests. And by relying on the Veeva
Professional Services team to help us load data and create reports for the
first three months of operation, we had an extraordinarily easy transition."

Veeva Systems has rapidly become the leading provider of Pharma CRM
solutions globally. As a multi-tenant SaaS application built in the cloud,
Veeva CRM requires no hardware or software to purchase, scale, or maintain.
In addition, all Veeva customers benefit from free, automatic upgrades so
users are always on the most up-to-date version of the software and benefit
from the very latest compliance changes and system enhancements. Changes can
be made to the system instantly, without user retraining or additional
third-party costs.

"By designing Veeva CRM to fit the specific requirements of the European
pharmaceutical industry, we have enabled companies like Iroko Cardio to
deploy quickly and painlessly," said Dan Goldsmith, general manager, Veeva
Europe. "And our truly multi-tenant technology platform anchors a solution
that our customers will never outgrow."

"The fact that Veeva's solution is cloud-based and therefore easy on our
IT infrastructure was very compelling," added Guenther. "Plus, we can add
promising new features later on, without undergoing massive development
projects."

About Iroko Cardio

Iroko Cardio is a privately held pharmaceutical company located in
Geneva, Switzerland, and Philadelphia, USA. In close collaboration with
regional distribution partners, Iroko produces and promotes
Aggrastat/Agrastat(R) worldwide with the exception of the USA. Iroko Cardio
aims to contribute to the reduction of Major Adverse Cardiac Events in the
regions it serves.

About Veeva Systems

Veeva Systems is the leader in cloud-based solutions for the global life
sciences industry. Committed to innovation, product excellence, and customer
success, Veeva has over 80 customers, ranging from the world's largest
pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a
privately-held company headquartered in the San Francisco Bay Area, with
offices in Philadelphia, Barcelona, Beijing, Shanghai, and Tokyo. For more
information, visit www.veevasystems.com.

Copyright (c) 2011 Veeva Systems. All rights reserved. Veeva and the
Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns
other registered and unregistered trademarks. Other names used herein may be
trademarks of their respective owners.

    Media Contact

    Selma Nawaz
    European Marketing Director
    Veeva Systems
    selma.nawaz@veevasystems.com

Media Contact: Selma Nawaz, European Marketing Director, Veeva Systems, selma.nawaz at veevasystems.com, +44(0)20-8638-0263

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :